HDPS-4II

HDPS-4II is described in the scientific literature as a compound investigated for its role in cancer development and treatment. Specifically, it has been referenced in the context of its relationship with **aldolase enzymes** in cancer, alongside L-carnosine. There is mention of anticancer peptides derived from ALDOA (aldolase A), such as peptide P04, increasing cancer cell sensitivity to HDPS-4II. However, detailed mechanistic, clinical, or chemical data are currently unavailable. The published literature clearly implicates HDPS-4II as an experimental or research-stage compound with putative anticancer activity, but does not provide further specificity on molecular mechanism, developer, or formulation[9].